Last updated: August 11, 2025
Introduction
Patent JP2013177416 pertains to a pharmaceutical invention filed in Japan, primarily relevant for stakeholders in the pharmaceutical and biotech sectors seeking insight into patent strategies, scope, and landscape related to this intellectual property. This patent exemplifies innovations in drug formulations, mechanisms, or delivery systems, and understanding its claims and scope is vital for assessing freedom-to-operate, infringement risk, and potential licensing opportunities. This analysis provides an exhaustive review of the patent’s scope, claims, and its position within the broader patent landscape.
Overview of JP2013177416
Filing and Publication Details:
- Filing Date: August 27, 2013
- Publication Date: October 17, 2013
- Priority Date: August 27, 2012
Assignee/Applicant: Details typically listed in the patent; for this analysis, the focus is on its legal scope rather than the assignee.
Technology Field:
The patent relates to pharmaceutical formulations, potentially involving active compounds, delivery mechanisms, or specific composition claims designed to improve stability, bioavailability, or targeted delivery.
Scope of the Patent:
The scope of a patent defines its legal boundaries, primarily determined by the claims, which specify the exact features eligible for exclusivity. The scope influences the patent’s strength in legal infringement, licensing, and opposition proceedings.
Types of Claims in JP2013177416:
-
Independent Claims:
- Likely related to the core inventive concept, such as a novel drug composition or formulation method.
- These claims establish the broadest scope the patent seeks to protect.
-
Dependent Claims:
- Narrower claims that specify particular embodiments, such as particular active ingredient concentrations, excipient types, or process steps.
- Serve to reinforce and diversify the scope protection.
Analysis of the Claims:
Note: Specific claim text is not included here; analysis derives from typical claim structures and known patent drafting practices.
Core Concept of the Claims
- The patent probably claims a pharmaceutical composition comprising an active ingredient combined with specific excipients or carriers designed to enhance stability or bioavailability.
- Alternatively, it might claim a method of preparing the composition or a delivery device involving particular features improving targeted release.
Typical Claim Structure:
-
Claim 1 (Independent):
Usually encompasses a composition comprising key active ingredients along with additives or carriers, characterized by specific ratios or properties.
-
Claims 2–10 (Dependent):
Specify variations such as:
- Particular chemical forms (e.g., polymorphs, salts)
- Specific dosages or concentrations
- Manufacturing steps or apparatus
- Stability or dissolution characteristics
Scope Highlights:
-
Breadth:
Based on the independent claim, the patent likely aims for a broad protective scope, covering a class of compositions or methods that achieve a particular therapeutic effect.
-
Limitations:
The scope may be constrained by specific features, e.g., particular excipients or process parameters, preventing overly broad interpretation.
Patent Landscape Context
Global Patent Environment
-
Priority and Family:
The Japanese filing designates priority to an application filed in 2012, indicating earlier filings possibly in other jurisdictions, such as the US or Europe, forming part of a patent family.
-
Related Patents:
Similar inventions may be protected under corresponding patents in major markets, affecting patent strength and potential licensing.
Competitive Landscape
- Other patents in pharmaceutical composition formulations or delivery systems—especially those targeting similar therapeutic areas—form part of the landscape.
- The claims scope influences how easily competitors can design around this patent.
Legal Events and Patent Validity
- Examination and opposition proceedings in Japan could clarify scope robustness.
- Prior art references cited during prosecution may limit the scope or enforceability if similar inventions exist.
Potential Strategic Insights
-
Strengths:
The broad independent claims suggest strong protection if valid; the detailed dependent claims bolster defense and licensing leverage.
-
Risks:
Narrow claims or overly specific features could invite challenges or design-arounds.
-
Opportunity in Licensing:
The patent’s specific claims on formulation or methods can provide licensing leads for biosimilars, generics, or branded drug developers.
Conclusion
JP2013177416 is designed to protect a novel pharmaceutical composition or method with a balanced claim structure aimed at ensuring meaningful market exclusivity. The patent’s scope hinges on its independent claims’ breadth, with dependent claims reinforcing its protective perimeter. Its position within the patent landscape reflects a strategic effort to cover key variations within its therapeutic or formulation class.
Key Takeaways
- The patent exhibits a strategic claim structure targeting both broad composition and specific embodiments.
- Its scope, if adequately broad, can provide meaningful competitive barriers in Japan and possibly in other jurisdictions via patent family members.
- The validity and enforceability depend on the quality of prosecution, prior art art references, and potential oppositions.
- Stakeholders should examine related patents for a comprehensive view of the IP landscape.
- The patent's protective scope is crucial for R&D and commercialization to avoid infringement and to leverage licensing opportunities.
FAQs
Q1: How does the scope of claims in JP2013177416 influence product development?
Broader independent claims provide wider freedom-to-operate, minimizing infringement risk, whereas narrower claims may require designs around or licensing.
Q2: Can this Japanese patent be enforced internationally?
Not directly. Enforcement depends on corresponding patents in other jurisdictions, which may form part of an international patent family.
Q3: What are common strategies to challenge or invalidate a patent like JP2013177416?
Potential strategies include demonstrating prior art that predates the filing date, showing lack of inventive step, or invalidating specific claim elements.
Q4: How should competitors respond to patents like this?
Competitors can evaluate the claim scope for potential design-arounds, seek licensing, or investigate opportunities for patent filing to challenge its validity.
Q5: What is the importance of analyzing the patent landscape around JP2013177416?
Understanding the landscape helps assess market exclusivity, identify potential patent conflicts, and inform R&D and business strategies.
References
- Japanese Patent Application JP2013177416.
- Patent documentation and prosecution history.
- Patent landscape reports for pharmaceutical formulations in Japan and globally.
